UnknownPhase 3

Efficacy and Safety of Colistin for Therapy of Infections Caused by ESBL Producing K.Pneumoniae or E.Coli

Thailand152 participantsStarted 2006-02

Plain-language summary

In patients with documented ESBL-producing E.coli and Klebsiella pneumoniae will be allocated to receive colistin or conventional antibiotic regimen.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age \> 18 yr. * Hospitalized to Siriraj Hospital * Infections with ESBL-producing E.coli or K.pneumoniae * Consent informed consent Exclusion Criteria: * Pregnancy or lactating mother * Colistin allergy * Neurologic diseases

What they're measuring

Clinical response

Trial details

NCT IDNCT00300560

SponsorMahidol University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Contact for this trial

Visanu Thamlikitkul, MD

662 419 7000 sivth@mahidol.ac.th

View on ClinicalTrials.gov More Infections trials